Monday, December 1, 2008 - 8:10PM EST

Drug Therapy

11. Early discontinuation of tamoxifen: a Lesson for oncologists.

Author
Barron TI; Connolly R; Bennett K; Feely J; Kennedy MJ;
Institution
Department of Pharmacology and Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland.
Journal
Cancer. 2007 Jan 22;.
Abstract URL
Click here to view abstract

12. Use of adjuvant systemic therapy for early breast cancer among women 65 years of age and older.

Author
Balasubramanian BA; Gandhi SK; Demissie K; August DA; Kohler B; Osinubi OY; Rhoads GG;
Institution
Department of Family Medicine, University of Medicineand Dentistry of New Jersey, Robert Wood Johnson MedicalSchool, Somerset, NJ 08873, USA. balasuba@umdnj.edu
Journal
Cancer Control. 2007 Jan;14(1):63-8.
Abstract URL
Click here to view abstract

13. Do endocrine treatments for breast cancer have a negative impact on lipid profiles and cardiovascular risk in postmenopausal women?

Author
Lewis S;
Institution
Northwest Cardiovascular Institute, Portland, OR 97210, USA. sandral@nw-ci.com
Journal
Am Heart J. 2007 Feb;153(2):182-8.
Abstract URL
Click here to view abstract

14. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

Author
Cuzick J; Ambroisine L; Davidson N; Jakesz R; Kaufmann M; Regan M; Sainsbury R;
Institution
Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. jack.cuzick@cancer.org.uk
Journal
Lancet. 2007 May 19;369(9574):1711-23.
Abstract URL
Click here to view abstract

15. Fulvestrant ('Faslodex') in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme.

Author
Mlineritsch B; Psenak O; Mayer P; Moik M; Namberger K; Hauser-Kronberger C; Greil R;
Institution
III Medical Department with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectious Disease, Paracelsus Private Medical University Salzburg, and Laboratory of Immunological and Molecular Cancer Research, Mullner Hauptstrasse 48, 5020 , Salzburg, Austria, r.greil@salk.at.
Journal
Breast Cancer Res Treat. 2007 Feb 13;.
Abstract URL
Click here to view abstract

16. Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers.

Author
Mazouni C; Kau SW; Frye D; Andre F; Kuerer H; Buchholz T; Symmans W; Anderson K; Hess K; Gonzalez-Angulo A; Hortobagyi G; Buzdar A; Pusztai L;
Institution
Department of Breast Medical Oncology.
Journal
Ann Oncol. 2007 Feb 10;.
Abstract URL
Click here to view abstract

17. Ovarian cancer risk in premenopausal and perimenopausal women treated with Tamoxifen: a case-control study.

Author
Swerdlow AJ; Jones ME;
Institution
1Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.
Journal
Br J Cancer. 2007 Feb 6;.
Abstract URL
Click here to view abstract

18. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

Author
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR; Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR;
Institution
Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. dlh23@columbia.edu
Journal
J Natl Cancer Inst. 2007 Feb 7;99(3):196-205.
Abstract URL
Click here to view abstract

19. Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma : pooled analysis of 2 consecutive trials.

Author
Boccardo F; Rubagotti A; Aldrighetti D; Buzzi F; Cruciani G; Farris A; Mustacchi G; Porpiglia M; Schieppati G; Sismondi P;
Institution
University and National Cancer Research Institute, Genoa, Italy.
Journal
Cancer. 2007 Feb 12;.
Abstract URL
Click here to view abstract
Pages: 1 2